Infection of the erythroid cell line, KU812Ep6 with human parvovirus B19 and its application to titration of B19 infectivity

Journal of Virological Methods

Volumn 83, Issue 1-2, 1999, Pages 45-54

  Miyagawa, Eiji ^a   Yoshida, Tsutomu ^a   Takahashi, Hirohiko ^b   Yamaguchi, Kazuhito ^c   Nagano, Tohko ^d   Kiriyama, Yoshiko ^d   Okochi, Kazuo ^d   Sato, Hiroyuki ^d  

^a FUJIREBIO INC   (Japan)

^b Onoda City Hospital   (Japan)

^c YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d Japanese Red Cross Kyushu Block Blood Center   (Japan)

Author keywords

Human parvovirus B19; KU812Ep6; TCID50

Indexed keywords

ARTICLE; HUMAN; HUMAN CELL; PARVOVIRUS; PRIORITY JOURNAL; VIRUS CELL INTERACTION; VIRUS GENOME; VIRUS INACTIVATION; VIRUS INFECTIVITY;

ANTIGENS, SURFACE; BASE SEQUENCE; CELL LINE; COLONY-FORMING UNITS ASSAY; DNA PRIMERS; ERYTHROCYTES; EVALUATION STUDIES; HEAT; HUMANS; MICROSCOPY, ELECTRON; PARVOVIRUS B19, HUMAN; POLYMERASE CHAIN REACTION; VIROLOGY; VIRULENCE;

DNA VIRUSES; PARVOVIRUS;

EID: 0032746342     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-0934(99)00105-6     Document Type: Article

References (36)

1. Anderson, M.J., Jones, S.E., Fisher-Hoch, S.P. Lewis, E., Hall, S.M., Bartlett, C.L., Choen, B.J., Mortimer, P.P., Pereira, M.S., 1983. Human parvovirus, the cause of erythema infectiosum (fifth disease)? Lancet I 1378.
2. Anderson M.J., Higgins P.G., Davis L.R., Willman J.S., Jones S.E., Kidd I.M., Pattison J.R., Tyrrell D.A.J. Experimental parvoviral infection in humans. J. Infect. Dis. 152:1985;257-265.
3. Anand A., Gray E.S., Broun T., Clewley J.P., Cohen B.J. Human parvovirus infection in pregnancy and hydrops fetalis. New Engl. J. Med. 316:1987;183-186.
4. Clewley J.P. Polymerase chain reaction assay for parvovirus B19 DNA in clinical specimens. J. Clin. Microbiol. 27:1989;2647-2651.
5. Cossart, Y.E., Cant, B., Field, A.M., Widdows, D., 1975. Parvovirus-like particles in human serum. Lancet I 72-73.
6. Fukuda T., Kishi K., Ohnishi Y., Shibata A. Bipotential cell differentiation of KU812: evidence of a hybrid cell line that differentiates into basophils and macrophage-like cells. Blood. 70:1987;612-619.
7. Hart H.F., Hart W.G., Crossley J., Perrie A.M., Wood D.J., John A., Mcomish F. Effect of terminal (dry) heat treatment on non-enveloped viruses in coagulation factor concentrates. Vox Sang. 67:1994;345-350.
8. Kishi K. New leukemia cell line with Philadelphia chromosome characterized as basophil precursors. Leuk. Res. 9:1985;318-390.
9. Kurtzman, G.J., Cohen, B., Mayers, P., Amunullah, A., Young, N.S., 1988. Persistent B19 parvovirus infection as a cause of severe chronic anemia in children with acute lymphocytic leukemia. Lancet ii 1159-1162.
10. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
11. Lefrere J.J., Mariotti M., Thauvin M. B19 parvovirus DNA in solvent/detergent-treated anti-hemophilia concentrates. Lancet. 343:1994;211-212.
12. Mortimer P.P., Humphries R.K., Moore J.G., Purcell R.H., Young N.S. A human parvovirus-like virus inhibits haemopoietic colony formation in vitro. Nature. 302:1983;426-429.
13. Mortimer, P.P., Luban N.L.C., Kelleher J.F., Cohen B.J., 1983. Transmission of parvovirus-like virus by clotting-factor concentrates. Lancet ii 482-484.
14. Munshi N.C., Zhou S., Woody M.J., Morgan D.A., Srivastava A. Successful replication of parvovirus B19 in human megakaryocytic cell line MB-02. J. Virol. 67:1993b;562-566.
15. Nakazawa M., Mitjavila M.T., Debili N., Casaderall N., Mayeux P., Rouyer-Fessard P., Dubart A., Romeo P., Beuzard Y., Kishi K., Breton-Gorius J., Vainchenker W. KU812: a pluripotent human cell line with spontaneous erythroid terminal maturation. Blood. 7:1989;2003-2013.
16. Ozawa K., Kurtzman G., Young N.S. Replication of B19 parvovirus in human bone marrow cell cultures. Science. 233:1986;883-886.
17. Ozawa K., Yu-shu J., Kurtzman G., Shimada T., Young N.S. Novel transcription map for B19 (human) pathogenic parvovirus. J. Virol. 61:1987;2395-2406.
18. Ozawa K., Ayub J., Young N. Translational regulation of B19 parvovirus capsid protein production by multiple upstream AUG triplets. J. Biol. Chem. 263:1988;10922-10926.
19. Pattison, J.R., Jones, S.E., Hodgson, J., Davis, L.R., White, J.H., Stroud, C.E., Murtaza, L., 1981. Parvovirus infection and hypoplastic crisis in sickle cell anemia. Lancet I 664-665.
20. Prowse C., Ludlam C.A., Yap P.L. Human parvovirus B19 and blood products. Vox Sang. 72:1997;1-10.
21. Reid, D.M., Reid, T.M.S., Brown, T., Rennie, J.A.N., Eastmond, C.J., 1985. Human parvovirus-associated arthritis: a clinical and laboratory description. Lancet I 422-425.
22. Reed L.J., Muench H. A simple method of estimating fifty per cent endpoints. Am. J. Hyg. 27:1983;493-497.
23. Roberts P.L. Severe heat treatment of freeze-dried coagulation factor concentrates: is hotter necessarily better? Vox Sang. 68:1995;61-62.
24. Saarinen U.M., Chorba T.L., Tattersall P., Young N.S., Anderson M.J., Palmer E., Coccia P.F. Human parvovirus B19 induced epidemic red cell aplasia in patients with hereditary hemolytic anemia. Blood. 67:1986;1411-1417.
25. Sambrook J., Fritsch E., Maniatis T. Molecular Cloning: a Laboratory Manual. 2nd edition:1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
26. Santagostino E., Mannucci P.M., Gringeri A., Azzi A., Morfini M. Eliminating parvovirus B19 from blood products. Lancet. 343:1994;798.
27. Sato H., Hirata J., Furukawa M., Kuroda N., Shiraki H., Maeda Y., Okochi K. Identification of the region including the epitope for a monoclonal antibody which can neutralize human parvovirus B19. J. Virol. 65:1991;1667-1672.
28. Sato H., Takakura F., Kojima E., Fukada K., Okochi K., Maeda Y. Screening of blood donors for human parvovirus B19. Lancet. 346:1995;1237-1238.
29. Serjeant, G.R., Mason, K., Topley, J.M., Serjean, B.M., Pattison,J.R., Jones, S.E., Mohammed, R., 1981. Outbreak of aplastic crisis in sickle cell anemia associated with parvovirus-like agents. Lancet ii 595-597.
30. Shimomura S., Komatu N., Frickhofen N., Anderson S., Kajigaya S., Young N.S. First continuous propagation of B19 parvovirus in a cell line. Blood. 79:1992;18-24.
31. Takahashi T., Ozawa K., Takahashi K., Asano S., Takaku F. Susceptibility of human erythropoietic cells to B19 parvovirus in vitro increase with differentiation. Blood. 75:1990;603-610.
32. Takahashi T., Ozawa K., Takahashi K., Okuno Y., Takahashi T., Muto Y., Takaku F., Asano S. DNA replication of parvovirus B19 in a human erythroid leukemia cell line (JK-1) in vitro. Arch. Virol. 131:1993;201-208.
33. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA. 76:1979;4350-4354.
34. White, D.G., Woolf, A.D., Mortimer, P.P., Cohen, B.J., Blake, D.R., Bacon, D.A., 1985. Human parvovirus arthropathy. Lancet I 419-421.
35. Yaegash N., Shiraishii H., Takeshita T., Nakamura M., Yajima A., Sugamura K. Propagation of human parvovirus B19 in primary culture of erythroid lineage cells derived from fetal liver. J. Virol. 63:1989;2422-2426.
36. Zerbini M., Musiani M., Venturoli S., Gallinella G., Gibellini D., Gentilomi G., Placa M.L. Rapid screening for B19 parvovirus DNA clinical specimens with a digoxigenin-labeled DNA hybridization probe. J. Clin. Microbiol. 28:1990;2496-2499.